March 1, 2023 -- BioAuxilium Research this week announced the expansion of its no-wash Thunder time-resolved Förster resonance energy transfer (TR-FRET) technology portfolio at the annual Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition in San Diego.
The company, a biotech tool company focused on facilitating access to fully validated assay kits to the biomedical research community, introduced six new biomarker research assay kits, a reader control kit, and an enhanced assay development service for drug discovery research.
BioAuxilium said it developed the new biomarker assays in response to customer requests for reliable cell-based assays that provide an alternative to expensive immunoassay platforms such as other TR-FRET and bead-based assay technologies.
The new offerings include a panel of six key mouse inflammatory cytokines (CCL-2/MCP1, IFN-beta, IFN-gamma, IL-2, IL-6, and TNF-alpha), expanding the company's portfolio to a total of 100 cell-based assay kits. The ready-to-use reader control kit allows users to assess in just 10 minutes the suitability of TR-FRET compatible microplate readers to perform Europium-based TR-FRET measurements, the firm said.
Copyright © 2023 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
